| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 43.71 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Recent research data have suggested the high therapeutical potential of gut microbiota modulation in numerous diseases. Nowadays, faecal transplantation, probiotics and prebiotics supplementation are strategies extensively used in the treatment of several disorders [1]. Prebiotic rich-foods play an important role in gut microbiota modulation. Beyond the rich nutritional value and various biological properties of mushrooms, several species have been described as prebiotics [2]. Prebiotics are defined as “a substrate that is selectively utilized by host microorganisms conferring a health benefit” [3]. Mushrooms also possess several health benefits such as antitumor, immunomodulatory, antioxidant and neuroprotective. This fact results in an increasing interest in identifying mushroom species and their bioactive molecules. Most research works focus on testing extracts or isolated compounds but a positive synergistic effect between molecules present in mushroom biomass has also been proposed [2]. In the present work, the mushroom biomass of Coriolus versicolor (CV), Hericium erinaceus (HE) and Pleurotus ostreatus (PO) species were chemically characterized and their main bioactive groups were identified and quantified towards the understanding of their biological potential.
